Search results for “non-small cell lung cancer (NSCLC)” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 3,105 patents, we discovered top 447 key players by total patent application. OncoTherapy Science, Inc., F. Hoffmann-La Roche Ltd., Cell Signaling Technology, Inc. are dominant in this area. They take 10.50% of the total patent filing.
Kanagawa-ken, Japan
Patent: 113
Switzerland
Patent: 113
Massachusetts, United States
Patent: 100
Baden-Württemberg, Germany
Patent: 83
Basel-Stadt, Switzerland
Patent: 68
California, United States
Patent: 67
Indiana, United States
Patent: 64
Cancer Prevention & Cure Ltd
United States
Patent: 62
Washington, United States
Patent: 54
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 47
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 69 patents, we discovered top 16 start-ups by total patent application. ALX Oncology, Inc., Ervaxx Ltd., NantOmics LLC are active in this area.
STARTUP
California, United States
Patent: 15
STARTUP
United Kingdom
Patent: 10
California, United States
Patent: 9
STARTUP
Guangdong Sheng, China
Patent: 8
STARTUP
Shanghai Shi, China
Patent: 3
STARTUP
South Korea
Patent: 3
Illinois, United States
Patent: 2
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
Sanomics Ltd.
Hong Kong SAR, China
Patent: 2
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 1,361 patents applied in the last 5 years. We discover 499 most active companies in this area. The fast-growing F. Hoffmann-La Roche Ltd., Genentech, Inc., Immatics Biotechnologies GmbH take 8.96% of patent filing during this period.
Switzerland
Patent: 43
California, United States
Patent: 41
Baden-Württemberg, Germany
Patent: 38
Hessen, Germany
Patent: 23
Jiangsu Sheng, China
Patent: 20
Basel-Stadt, Switzerland
Patent: 19
New York, United States
Patent: 17
New York, United States
Patent: 16
STARTUP
California, United States
Patent: 15
Jiangsu Sheng, China
Patent: 15
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 1,361 patents in last 5 years, we discover 360 new entrants. ALX Oncology, Inc., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Palo Biofarma SL are the most active new entrants in this area.
STARTUP
California, United States
Patent: 15
Jiangsu Sheng, China
Patent: 15
Spain
Patent: 12
Shanghai Shi, China
Patent: 11
United Kingdom
Patent: 11
STARTUP
United Kingdom
Patent: 10
Zhejiang Sheng, China
Patent: 10
Genmab A/S
Hovedstaden, Denmark
Patent: 9
Shanghai Shi, China
Patent: 9
Guangdong Sheng, China
Patent: 8
Research Institutions
Order by:
Innovation Intensity
With the analysis among 947 patents, we discovered top 206 universities and scientific research institutions by total patent application. Macau University of Science & Technology, Shanghai Institute of Materia Medica Chinese Academy of Sciences, Sichuan University are dominant in this area. They take 5.81% of the total patent filing.
Macao SAR, China
Patent: 18
Shanghai Shi, China
Patent: 17
Sichuan Sheng, China
Patent: 15
Ohio, United States
Patent: 13
Shanghai Shi, China
Patent: 13
California, United States
Patent: 12
Shanghai Shi, China
Patent: 12
Central Region, Singapore
Patent: 11
Jiangsu Sheng, China
Patent: 11
North Carolina, United States
Patent: 10
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: